Turbo Cancer: New Pre-Print Points Directly to mRNA ‘Vaccines’ & Testimony From the Allison Inquiry

September 18, 2026

Sep 17, 2026

“This is the smoking gun for turbo cancers,” Nicolas Hulscher, an epidemiologist, tells Dr. Drew and Dr. Kelly Victory.

He says a new case study shows synthetic Pfizer mRNA vaccine plasmid fragments recovered directly from the aggressive tumor of a 35-year-old male.

“He received these mRNA injections. And then about 100 days later, he went to the ER and they found a giant cardiac sarcoma that was filling up his left atrium,” says Hulscher. “He got a booster, and then it spread to his brain, and he died because of bleeding into his brain stem.”

The paper, titled “Fatal Cardiac Intimal Sarcoma in a 35-Year-Old Male Following COVID-19 mRNA Vaccination,” details a previously healthy man whose tumor demonstrated an explosive 10-day doubling time. Tissue testing identified three synthetic spike-encoding fragments and the plasmid origin-of-replication sequence embedded within the tumor tissue.

“These were literally inside of that tumor,” says Nic. “We find the weapon at the scene of the crime now. And so turbo cancer is not a myth. It’s very real.”

Go here for the McCullough Foundation’s comprehensive library of peer-reviewed publications. You will not find the cardiac sarcoma as it is a pre-print and has not been peer-reviewed.

__________________

The Allison Inquiry in Canada is the first inquiry by Canadian lawmakers into COVID-19 injection injuries. It is chaired by Member of Parliament Dean Allison and is non-partisan.

Approx. 11 Min

Sept. 14, 2026

Sen. Ron Johnson and Canadian MP Chris Lewis discuss alleged COVID-19 vaccine side effects and “turbo cancer” claims at the Allison Inquiry in Canada. Johnson raises questions about COVID vaccine safety, cancer, clinical-trial data and Pfizer’s unblinding, while Lewis shares his mother’s cancer story after vaccination.

The explosive Parliament Hill hearing has reignited debate over COVID-19 vaccines, vaccine injuries, cancer claims and the handling of long-term safety data.

Sept. 13, 2026

Former WHO Director Breaks Silence on ‘Vaccine’ Injury

“I was this grotesque, unrecognizable version of myself.” ~ Patricia Leidl

Sept. 11, 2026

Veteran Detective Helen Grus was suspended, charged with discreditable conduct, and subjected to a multi-year disciplinary tribunal after she noticed a sudden spike in unexplained infant deaths, which caused her to look into the department’s database and flag the trend to her superiors.

Sept. 10, 2026

Carrie Sakamoto describes severe neurological complications, including facial paralysis and spinal problems, which she says followed COVID-19 shot.

Sept. 9, 2026

After 40 years of active construction work and robust health, 74-year-old John Philip Grant experienced sudden, life-threatening hematological and pulmonary complications after the COVID shot.

“My blood platelets had gone down to zero… I didn’t know if I was going to live.”

For more:

Category:

Activism, vaccines, Viruses

Comments Off on Turbo Cancer: New Pre-Print Points Directly to mRNA ‘Vaccines’ & Testimony From the Allison Inquiry

ACTION: Repeal the 1986 Vaccine Law

September 17, 2026

https://kirschsubstack.com/p/help-us-reach-50000-signatures-to

Help us reach 50,000 signatures to repeal the 1986 vaccine law

If you can only take one action this year, this should be your top choice.

Steve Kirsch

Sep 16, 2026

I’m again asking you to sign our petition to repeal the 1986 vaccine law.

For 40 years, vaccine manufacturers have been protected from legal responsibility when their products injure people.

Now, bills to repeal the 1986 law are finally before both chambers of Congress. We have a real chance to change the law. The tide is turning in our favor.

We are at just over 20,000 signatures. Our next goal is 50,000.

We had some technical issues with a previous version of the petition form. Those problems have been fixed.

You don’t have to be an American to sign. We welcome signatures from around the world.

I signed it. It takes less than a minute.

_________________

I highly recommend reading/watching NVIC’s “1986 National Childhood Vaccine Injury Act: Myth vs. Fact.“

It is NVIC’s position that the 1986 National Childhood Vaccine Injury Act should return to its original form before the vaccine safety, civil liability and compensation provisions were destroyed by weakening congressional amendments, agency rule making changes, and the tragically flawed U.S. Supreme Court decision effectively removing product design defect liability from vaccine manufacturers.

For more:

Category:

Activism, vaccines

Comments Off on ACTION: Repeal the 1986 Vaccine Law

After These Young People Died, Postmortems Found an Unnerving Parasite Link

September 15, 2026

After These Young People Died, Postmortems Found an Unnerving Parasite Link

04 September 2026

ByEsra Öz

After These Young People Died, Postmortems Found an Unnerving Parasite Link (Breitschwerdt et al., Parasites & Vectors, 2026, CC BY 4.0.)

He had been athletic and healthy. Then came years of exhaustion, pain, memory problems, and psychiatric symptoms. Eventually, he had to leave college.

By the time the 27-year-old died, six years of illness and specialist care had failed to restore his health.

Tests performed after his death revealed DNA from two species of Babesia, tiny parasites that infect red blood cells, and Bartonella henselae, the bacterium that causes cat-scratch disease.

His was one of six cases in a postmortem investigation driven by families still seeking answers about their children’s illnesses.

Researchers confirmed DNA from one or both groups of microbes in five individuals.

The discovery left a crucial question unanswered: what role, if any, had these infections played in their illnesses?

The individuals were aged 14 to 30, and all had experienced chronic illness and suicidal thoughts or behaviors.

Four died by suicide, one through medical assistance in dying, and another from a severe disorder involving excessive immune activation.

Their parents contacted Edward Breitschwerdt, an infectious disease researcher at North Carolina State University, after learning about his team’s work on Bartonella and neurological illness. (See link for article)

_________________

**Comment**

This is the perfect article to follow up on the research on ‘PTLDS’ as it wonderfully shows how these pathogens are hard to find let alone effectively treat but are causing needless suicides and unbelievable suffering, due to an old faulty dogma that refuses to go away.

Important excerpt:

“They supplied medical histories and arranged for postmortem samples to reach his laboratory. Some had already been tested or treated for these infections while alive. The investigation was therefore not the first indication of infection in every case. At the laboratory, the initial search returned no clear answers. The researchers analyzed 125 DNA extracts from blood, laboratory blood cultures, tissues, and other body fluids. Initial quantitative PCR screening, which searches for selected genetic sequences, was negative throughout. Digital PCR, which divides samples into many tiny reactions, then produced faint signals in some samples. None reached the study’s threshold for a positive result. Additional targeted tests and DNA sequencing, which reads genetic material to identify organisms, provided confirmation.”

These poor folks would have been ignored by most researchers after the PCR screening, but Bart guru, Dr. Ed Breitschwerdt, is no dummy and kept digging. Notice they did additional ‘targeted’ tests AND DNA sequencing. Mainstream research simply quits looking after using tests that are wrong nearly 90% of the time.

In response to the question of whether the DNA points to an active infection at the time of death, Breitschwerdt said that detecting a known pathogen’s DNA in clinical specimens is medically accepted as evidence of “active infection.

Yet – for some reason, this ‘medically accepted’ evidence does NOT hold true for Lyme/MSIDS. It’s the perfect quagmire with no end in sight.

While this was an ‘observational study’, not a prospective case-controlled study, Breitschwerdt states:

“I think the best interpretation is that infections with vector-borne pathogens that have evolved to induce persistent infections in animals and human patients are not a current diagnostic consideration in patients with chronic illnesses or neuropsychiatric symptoms.”

For more:

Category:

Babesia, Bartonella, Inflammation, Lyme, Psychological Aspects, research, Testing

Comments Off on After These Young People Died, Postmortems Found an Unnerving Parasite Link

Designing Studies For Post-Treatment Lyme Disease and Other Infection-Associated Chronic Illnesses

https://academic.oup.com/brain/article/149/6/1842/8586348

Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses 

Paul M Arnaboldi, Jacqueline Becker, Avindra Nath, Patricia K Coyle, Andrew Handel, Timothy J Sellati, Maria Gomes-Solecki, Sandra Garcet, Marianne K Henderson, Piper Mullins,… Show more

Brain, Volume 149, Issue 6, June 2026, Pages 1842–1859, https://doi.org/10.1093/brain/awag016

Published: 18 May 2026

Abstract

Infection-associated chronic illnesses (IACIs) encompass a spectrum of poorly understood syndromes often marked by significant neurologic and multisystem symptoms following an infectious event.

This review focuses on several diseases representative of the IACI spectrum. These are post-treatment Lyme disease syndrome (PTLDS), long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis (MS). Their clinical and biological complexity, combined with a lack of clear diagnostic criteria and objective available laboratory biomarkers, makes them difficult to distinguish from conditions with overlapping features. This presents challenges for research studies, as well as diagnosis and clinical management. This diagnostic ambiguity, coupled with heterogeneous patient presentations, has led to challenges in research, including misclassification of study participants and inconsistent or irreproducible findings. Some PTLDS research exemplifies these issues, which also extend to other IACIs.

To advance the field, we highlight key methodological refinements and approaches for studying IACIs, including rigorous participant selection, standardized sample collection protocols, and the use of appropriate control groups, including those with microbiologic proof of the initial infection when known and technologically feasible. We also address broader influences on research quality, such as stigma, historical neglect, and the urgency to find treatments, which have contributed to the proliferation of poorly controlled studies and questionable practices. Drawing lessons from past challenges, we propose a path forward grounded in fit-for-purpose methodological rigor to improve scientific understanding and support evidence-based therapeutic development for IACIs. (See link for full article)

________________

**Comment**

I’m not going to do a full write up of this, but am simply going to point out an error right away in paragraph two which states, “antibiotic therapy is effective for clearing the bacterium.” For years research has shown that this is simply not the case with a subset of patients. There are numerous reasons for this including the involvement of coinfections antibiotics won’t touch, and using an ineffective antibiotic, for the wrong duration of time as research has shown many of these pathogens have the ability to sequester in tissues in a dormant state when threatened by treatment only to reemerge later when conditions are favorable. Again, for a vast majority of patients who are infected with multiple pathogens simultaneously, an antiquated and ineffective CDC monotherapy simply will not and can not work.

As I’ve written previously, I take issue with the accepted post-treatment Lyme disease syndrome (PTLDS) moniker since the ‘post treatment’ is based upon the entirely false premise that 10 days of doxycycline ‘cures’ Lyme disease. This tenet has been proven false again and again yet is regurgitated as an unquestionable rule. All you have to do is look around and see thousands still suffering after this supposed ‘gold standard’ therapy.

The authors also state that ‘Chronic Lyme Disease’ (CLD) is ‘used by some to describe individuals with a vague array of symptoms, frequently lacking documentation of exposure to Bb.

So, in paragraph two they already tip their hand that they are simply old school players who buy the clap-trap that Lyme is simple to identify, prove, and treat when everyone and their dog knows this belief belongs in the same category as pixie dust. A test that can be wrong nearly 90% of the time is no test that should be taken seriously by anyone. Diagnosis remains a ‘clinical’ one and anyone who says other wise is an ostrich with their head in the sand.

Important excerpt:

“In this review, we focus on and refer to PTLDS using criteria proposed and generally accepted by most academic and government agencies.4,9-11 Individuals with PTLDS had laboratory and clinically supported evidence of B. burgdorferi infection. They received appropriate early antibiotic therapy9,12 and continued to have or develop new symptoms within 6 months of infection that lasted for a period of at least 6 months, resulting in impaired or declining function.”

This is all I need to know. They will find nothing of value for sick patients. Zip. Nadda.

Until the world wakes up to the uniqueness of this complex illness, we simply circle the drain.

For more:

Category:

Lyme, research

Comments Off on Designing Studies For Post-Treatment Lyme Disease and Other Infection-Associated Chronic Illnesses

Chronic Lyme, Morgellons & the Fight For Better Care

This week on What the Morgs?, host Britt Girvan sits down with Dr. Raphael Stricker, a physician at Union Square Medical Associates in San Francisco and longtime advocate for patients with Lyme disease and tick-borne illness. Dr. Stricker is a past President of the International Lyme and Associated Diseases Society (ILADS), serves on the board of LymeDisease.org and the Lyme Disease Advisory Committee, and has authored more than 200 medical publications.

In this episode, Britt and Dr. Stricker discuss the challenges surrounding Lyme disease diagnosis and treatment, chronic Lyme symptoms, current vaccine research, tick-borne co-infections, Morgellons disease, and the barriers many patients face when searching for answers and appropriate care.

Topics Discussed:

-Lyme disease diagnosis, chronic symptoms, and common misconceptions

Dr. Stricker discusses the limitations he sees in current Lyme disease testing, what can make diagnosis difficult, how chronic symptoms are defined, and why patients with persistent symptoms may struggle to receive appropriate care. He also shares his perspective on the current Lyme disease vaccine landscape.

-The connection between Lyme disease and Morgellons disease Britt and Dr. Stricker explore Morgellons disease, the physical symptoms patients experience, research examining Morgellons fibers and skin lesions, and the history of patients being dismissed or characterized as delusional. They also discuss the importance of clinicians taking patients’ experiences seriously and continuing to investigate the condition.

-Co-infections, treatment approaches, and neurological symptoms Dr. Stricker discusses current research into tick-borne co-infections such as Babesiosis, his use of combination antibiotic therapy, and approaches used in his practice for patients experiencing neurological symptoms such as brain fog and cognitive difficulties. He also explains why treatment can vary significantly from one patient to another.

About What The Morgs? Podcast: What The Morgs? is a podcast for people navigating Lyme and Morgellons disease. Hosted by Britt Girvan, the show is built on a mission to support, educate, and empower those affected—turning personal struggle into shared strength and purpose. What The Morgs? Website: https://whatthemorgs.com/

For more:

Another Lyme OspA Vaccine Whitewash
The meta-analysis by Zhao and colleagues comes to the conclusion that “the OspA vaccine against Lyme disease is safe and its immunogenicity and efficacy have been verified.” The authors arrive at this sunny conclusion by excluding 99.6% of published articles that demonstrate potential problems with the OspA vaccine. Furthermore, the authors ignore peer-reviewed studies, FDA regulatory meetings and legal proceedings that point to major problems with OspA vaccine safety (1-3). This whitewash bodes ill for future Lyme vaccine candidates because it fosters disregard for vaccine safety among Lyme vaccine manufacturers and mistrust among potential Lyme vaccinees.

Category:

Lyme, Morgellons, Treatment, vaccines

Comments Off on Chronic Lyme, Morgellons & the Fight For Better Care